These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8284263)

  • 1. Conformational analysis of synthetic peptides encompassing the factor XI and prekallikrein overlapping binding domains of high molecular weight kininogen.
    You JL; Page JD; Scarsdale JN; Colman RW; Harris RB
    Peptides; 1993; 14(5):867-76. PubMed ID: 8284263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calorimetric and spectroscopic examination of the solution phase structures of prekallikrein binding domain peptides of high molecular weight kininogen.
    You JL; Scarsdale JN; Harris RB
    J Protein Chem; 1991 Jun; 10(3):301-11. PubMed ID: 1910462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution phase conformation studies of the prekallikrein binding domain of high molecular weight kininogen.
    Scarsdale JN; Harris RB
    J Protein Chem; 1990 Oct; 9(5):647-59. PubMed ID: 2085389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of the binding site on plasma kallikrein for high-molecular-weight kininogen to both apple 1 and apple 4 domains of the heavy chain.
    Page JD; You JL; Harris RB; Colman RW
    Arch Biochem Biophys; 1994 Oct; 314(1):159-64. PubMed ID: 7944388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structures of factor XI and prekallikrein bound to domain 6 of high-molecular weight kininogen reveal alternate domain 6 conformations and exosites.
    Li C; Barroeta AB; Wong SS; Kim HJ; Pathak M; Dreveny I; Meijers JCM; Emsley J
    J Thromb Haemost; 2023 Sep; 21(9):2378-2389. PubMed ID: 37068593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical and biological significance of peptide sequences mediating the interaction between high molecular weight kininogen and plasma prekallikrein.
    Colman RW; Lin Y; Yan WY; McCrae KR; Shenoy SS; Harris RB
    Immunopharmacology; 1997 Jun; 36(2-3):193-200. PubMed ID: 9228546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct evidence for multifacial contacts between high molecular weight kininogen and plasma prekallikrein.
    Lin Y; Shenoy SS; Harris RB; Colman RW
    Biochemistry; 1996 Oct; 35(39):12945-9. PubMed ID: 8841140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary structure requirements for the binding of human high molecular weight kininogen to plasma prekallikrein and factor XI.
    Tait JF; Fujikawa K
    J Biol Chem; 1987 Aug; 262(24):11651-6. PubMed ID: 3650269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of the H-kininogen binding site exposed by the prekallikrein heavy chain.
    Herwald H; Hock H; Jahnen-Dechent W; Müller-Esterl W
    Agents Actions Suppl; 1992; 38 ( Pt 1)():225-32. PubMed ID: 1466274
    [No Abstract]   [Full Text] [Related]  

  • 10. Mapping of the high molecular weight kininogen binding site of prekallikrein. Evidence for a discontinuous epitope formed by distinct segments of the prekallikrein heavy chain.
    Herwald H; Jahnen-Dechent W; Alla SA; Hock J; Bouma BN; Müller-Esterl W
    J Biol Chem; 1993 Jul; 268(19):14527-35. PubMed ID: 7686159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The shape of high molecular weight kininogen. Organization into structural domains, changes with activation, and interactions with prekallikrein, as determined by electron microscopy.
    Weisel JW; Nagaswami C; Woodhead JL; DeLa Cadena RA; Page JD; Colman RW
    J Biol Chem; 1994 Apr; 269(13):10100-6. PubMed ID: 8144509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the H-kininogen-binding site on factor XI: a comparison of factor XI and plasma prekallikrein.
    Renné T; Gailani D; Meijers JC; Müller-Esterl W
    J Biol Chem; 2002 Feb; 277(7):4892-9. PubMed ID: 11733491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chain.
    Thompson RE; Mandle R; Kaplan AP
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):4862-6. PubMed ID: 291905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping of the discontinuous kininogen binding site of prekallikrein. A distal binding segment is located in the heavy chain domain A4.
    Herwald H; Renné T; Meijers JC; Chung DW; Page JD; Colman RW; Müller-Esterl W
    J Biol Chem; 1996 May; 271(22):13061-7. PubMed ID: 8662705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of high molecular weight kininogen and prothrombin as cofactors in the binding of factor XI A3 domain to the platelet surface.
    Ho DH; Badellino K; Baglia FA; Sun MF; Zhao MM; Gailani D; Walsh PN
    J Biol Chem; 2000 Aug; 275(33):25139-45. PubMed ID: 10823824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of high-molecular-mass kininogen to the Apple 1 domain of factor XI is mediated in part by Val64 and Ile77.
    Seaman FS; Baglia FA; Gurr JA; Jameson BA; Walsh PN
    Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):715-21. PubMed ID: 7818472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping of the prekallikrein-binding site of human H-kininogen by ligand screening of lambda gt11 expression libraries. Mimicking of the predicted binding site by anti-idiotypic antibodies.
    Vogel R; Kaufmann J; Chung DW; Kellermann J; Müller-Esterl W
    J Biol Chem; 1990 Jul; 265(21):12494-502. PubMed ID: 1695630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of the high molecular weight kininogen binding site in the heavy chain of human factor XI to amino acids phenylalanine 56 through serine 86.
    Baglia FA; Jameson BA; Walsh PN
    J Biol Chem; 1990 Mar; 265(7):4149-54. PubMed ID: 2105959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contact activation proteins: a structure/function overview.
    Meijers JC; McMullen BA; Bouma BN
    Agents Actions Suppl; 1992; 38 ( Pt 2)():219-30. PubMed ID: 1462829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor XI binding to activated platelets is mediated by residues R(250), K(255), F(260), and Q(263) within the apple 3 domain.
    Ho DH; Baglia FA; Walsh PN
    Biochemistry; 2000 Jan; 39(2):316-23. PubMed ID: 10630991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.